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Abstract
As populations in many parts of the world are projected to become more racially diverse over the coming decades, we must
better understand the unique characteristics of the skin of populations with skin of color (SOC). This review aims to highlight important physiologic and clinical considerations of photoprotection in SOC. Ultraviolet radiation and visible light
affect dark and light skin differently. SOC populations have historically not been informed on photoprotection to the same
degree as their light skinned counterparts. This has exacerbated dermatologic conditions in which SOC populations are
disproportionately affected, such as hyperpigmentary disorders. Patients should be encouraged to utilize multiple methods
of photoprotection, ranging from avoidance of sunlight during peak intensity hours, seeking shade, wearing sun-protective
clothing and wide-brimmed hat, and applying sunscreen. Ideal sunscreens for SOC populations include those with UVAPF/SPF ratios ≥ 2/3 and tinted sunscreens to protect against VL. Although there have been increased efforts recently, more
research into photoprotection for SOC and targeted public education are required to disseminate photoprotection resources
that are patient-centered and evidence-based.
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Abbreviations
FST	Fitzpatrick skin typing
ITA	Individual typology angle
MED	Minimal erythema dose
MMP	Matrix metalloproteinase
PIH	Post-inflammatory hyperpigmentation
ROS	Reactive oxygen species
SOC	Skin of color
SPF	Sun-protection factor
SPT	Skin phototypes
UPF	Ultraviolet protective factor
UV	Ultraviolet
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UVR	Ultraviolet radiation
VL	Visible light

1 Introduction
Increased education and awareness of skin conditions disproportionately seen in pigmented skin is crucial to championing equitable care and optimizing patient outcomes [1].
As populations in many parts of the world are projected to
become more racially diverse over the coming decades, we
must better understand the unique characteristics of the skin
of populations with skin of color (SOC) [2].
SOC has many unique biological considerations. Ultraviolet (UV) radiation and visible light (VL) do not affect
dark and light skin in the same ways [3]. Understanding the
science behind effects of UV and VL on dark skin will help
clinicians better inform patients—and the public at large—
on photoprotective recommendations.
SOC populations have historically not been counseled
on photoprotection to the same degree as their light skinned
counterparts [4]. This has exacerbated the prevalence and
severity of dermatologic conditions in which SOC populations are disproportionately affected, such as hyperpigmentary disorders. The scientific community has thus increased
efforts to dispel misconceptions and provide practice recommendations on photoprotection for SOC [5].
The aim of this review is to highlight important physiologic and clinical considerations of photoprotection in SOC.
We will discuss reaction to UV and VL, biological response
to UVA and UVB protection, and advise on photoprotection
for SOC populations.

2 Methods
We conducted a narrative review of the literature. A literature search of PubMed and GoogleScholar using the terms
“photoprotection,” “skin of color,” “dark skin, “black skin,”
“ethnic skin,” “sunscreen,” “visible light,” “ultraviolet
light,” “photoaging,” and “photodamage” in various combinations was performed. This literature search was limited
to articles in English. The search was not limited by year of
publication. One hundred fifty-four articles were identified
on PubMed and 2590 articles on GoogleScholar. Articles
were selected for inclusion depending on subjective relevance. One hundred thirty-four articles were included in
this review.

2.1 Assessing skin phototype
The racial and ethnic diversity of populations in many parts
of the world is changing substantially. In the United States,

13

for example, population projections suggest more than onehalf of the U.S. population will be non-white by the year
2050 [6]. A similar phenomenon have been described in
the UK [7]. These changing demographics underscore the
importance of increased education and awareness of concerns in pigmented skin to ensure optimal health outcomes
in the future [8]. In North America, SOC generally refers
to individuals of African, Asian, Native American, Middle
Eastern, and Hispanic (or Latino) descent [9]. Fitzpatrick
skin typing (FST), the most commonly used classification
system in dermatology, was originally designed to categorize Caucasian skin into four Fitzpatrick skin phototypes
(SPT), I–IV [10]. SPT V–VI were later added to enable
classification of darker skin tones. For SPT I–IV, classification is made by the propensity of the skin to burn or tan
following sun exposure. For dark skin types (SPT V–VI),
determination is made by the color of the skin (Table 1).
There are some variations in the definition of SOC among
articles, with some including SPT III as SOC. For this article, we did not limit SOC to SPT IV–VI given the diversity
of ethnic skin types across the SPT scale, and thus used the
varying classifications used in each of the reviewed articles.
Additionally, many studies use ethnicity or skin color rather
than SPT to describe subjects, making translation of all cited
studies to SPT values impossible given the limited information provided in these articles.
Skin phototyping is useful in predicting the risk of acute
and chronic photodamage, photocarcinogenesis and the outcome of esthetic procedures. FST is often misinterpreted; a
survey of academic dermatologists and dermatology trainees in the U.S. found that approximately one-third to half
of these providers use FST as a means of describing race/
ethnicity and constitutive skin color [11]. This misuse occurs
more frequently among physicians who do not identify as
having SOC [8, 11]. Although individuals with SOC are
often regarded as having SPT III, IV, V, and VI, ethnic skin
colors span the entire spectrum of phototypes and do not
always match the FST categories [12–14]. While SPT has
been widely used in clinical settings for phototherapy, classification systems that more objectively assess skin UV sensitivity/response are needed to accurately determine cancer
risk in racially and ethnically diverse patients [13, 15–17].
Table 1  Fitzpatrick skin phototypes
Skin phototype Description
I
II
III
IV
V
VI

Always burns, never tans
Burns easily, sometimes tans
Sometimes burns, always tans
Rarely burns, tans easily
Rarely burns, tans easily, moderately pigmented skin
Rarely burns, tans well, highly pigmented skin
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Diffuse reflectance spectrophotometry objectively measures
the melanin index and is the most reliable way to assess the
color of the skin, however, it is not practical to use in routine
clinical settings due to the expertise, time and associated
cost needed [16]. A colorimeter-based assessment of skin
color, individual typology angle (ITA), has increasingly
been accepted as an objective and reproducible method to
assess skin color, especially in photodermatology research
[10]. The equipment however is costly, and its use requires
specialized training. Therefore, for use in the clinics, FST is
still the widely used method.

2.2 Electromagnetic radiation
The sun emits energy in a wide range of electromagnetic
wavelengths classified into different spectral regions (Fig. 1).
The shorter the wavelength, the more energetic the radiation and the greater potential for adverse biological effects
[18]. UV radiation (UVR) is in wavelengths between 100
and 400 nm; while there are several variations on subdivision of UV spectrum, in photodermatology, the most widely
used one is UVC (200–290 nm), UVB (290–320 nm), and
UVA (320–400 nm). Visible light (VL) is characterized by
wavelengths ranging from 400 to 700 nm. Melanin, one of
the naturally occurring chromophores in the skin, absorbs
throughout the UVB, UVA, and visible wavelengths [19].

2.3 Effects of ultraviolet radiation
The biological processes associated with exposure to UVR
can be divided in to acute and chronic effects. Acute UV
exposure induces the production of inflammatory, vasoactive and neuroactive mediators that together result in an
inflammatory response and cause erythema (sunburn) [20].
Physiologic responses to protect the skin against subsequent
UV damage occur including adaptive melanization (tanning)
and epidermal hyperkeratosis. If the dose of UV exceeds a
threshold damage response, keratinocyte death occurs via
apoptosis. UVB is more damaging per unit of physical dose
(ie, J/cm2) compared to UVA. It dominates the carcinogenic
effects of sunlight by causing direct DNA damage, while
UVA causes indirect damage mainly through the production of reactive oxygen species (ROS) [3]. Erythema (sunburn) is mainly caused by UVB radiation, although UVA
and visible light can also contribute [21, 22]. Chronic UV

exposure results in photoaging and photocarinogens, most
prominently seen in light-skinned individuals. Although
these acute and chronic effects are well understood, the
differences in UV effects between light skinned and darkskinned subjects are beginning to be elucidated. In addition
to being more resistant to DNA damage, dark skin has been
suggested to be better adept at DNA damage repair compared to light skin [23]. Sheehan et al. compared biopsies
of individuals with phototype II and IV using monoclonal
antibodies for thymine dimers; this study reported a greater
loss of thymine dimers in skin type IV, suggesting that rates
of DNA repair are greater in the dark skin [24].
2.3.1 Photoprotective role of melanin
Melanin functions as a physical barrier that scatters UVR
and reduces penetration through the epidermis. The epidermis of dark skin is estimated to have an intrinsic SPF
of 13.4, whereas light skin has an SPF of 3.3 [23]. This
is primarily thought to be a result of differences in melanocyte size and melanosome distribution and packaging
[25]. Melanocytes produce two main types of melanin from
dihydroxyphenylalanine precursors: yellow–red pheomelanin and black-brown eumelanin. Eumelanin is superior in its
photoprotective properties, and the proportion of eumelanin
to pheomelanin has implications on skin type. Differences
in size, number and packaging of melanosomes, the type of
melanin produced, and the melanin content of melanosomes,
which can range from 17.9 to 72.3%, determines skin pigmentation [3]. SOC has comparatively larger melanocytes,
higher eumelanin/ pheomelanin ratio, and melanosomes
that are distributed individually in keratinocytes rather than
in aggregates, allowing for more efficient absorption [26].
This increased epidermal melanin and distribution provides
an inherent photoprotection and allows for absorption and
scattering of two to five times more UV photons. For a given
exposure to UVR, individuals with less epidermal melanin
will exhibit greater erythema and less tanning than persons
with more melanin [27]. There are also skin type differences
in melanosome degradation. Melanosomes in dark skin are
resistant to degradation by lysosomal enzymes and remain
intact throughout the epidermal layers [3, 28]. Melanosomes
in fair skin are degraded and only persist as “melanin dust”
in the suprabasal layers.

Fig. 1  Electromagnetic radiation spectrum
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Tadokoro et al. explored the relationship between melanin content and DNA damage in individuals from different
racial/ethnic origins and different phototypes [29]. After
exposure to 1 minimal erythema dose (MED) of UVR (60%
UVA and 40% UVB), subjects from all groups suffered significant DNA damage and this damage was greatest immediately following UV exposure. The extent of DNA damage
was inversely correlated with skin pigmentation. Del Bino
et al. assessed the relationship between UV sensitivity and
skin color type by analyzing DNA damage, apoptosis and
p53 accumulation in skin samples after UV exposure. Rather
than using SPT, they classified skin samples into five categories (light, intermediate, tanned, brown and dark) according
to their ITA value. The lower the ITA value, the darker the
skin color type. They found that in light, intermediate and
tanned skin types, DNA damage was observed to be distributed throughout the epidermis and superficial dermis while
in brown and dark skin types, they were present only in the
suprabasal layers [30].
2.3.2 Photoaging
Long-term exposure to UVR causes premature aging
through a sequence of specific molecular responses that
damage skin connective tissue. UVR is directly absorbed
by DNA, giving rise to genomic alterations varying from
point mutations to chromosomal rearrangements. Photochemical generation of ROS also causes deleterious chemical modifications to DNA and other cellular components
through photosensitizing reactions [18]. Accumulation
of protein and DNA damage leads to delayed effects and
characteristic morphological changes in keratinocytes and
other skin cells. UV penetrates the skin in a wavelengthdependent manner. While both UVA and UVB contribute to
photoaging, the longer wavelength of UVA is able to reach
the deep dermis and thus plays a greater role in premature
aging; UVB, in contrast, is almost completely absorbed by
the epidermis [18]. Skin of SPT III–VI is better protected
against UV-induced damage than skin of SPT I–II because
it is more effective in inhibiting UV penetration, typically
allowing penetration of 7.4% UVB and 17.5% UVA, compared to 29.4% and 55.5% respectively, for white skin [31].
Melanin not only acts as a physical barrier to UV, it also has
antioxidant and radical scavenging properties, so response to
oxidative stress also differs between skin types [3].
UVR induces alterations in the collagenous extracellular
matrix of connective tissue. These alterations include fragmentation of collagen fibrils and accumulation of abnormal
elastin-containing material. UV stimulates activator protein
1, which leads to upregulation of matrix metalloproteinase (MMP) and inhibition of transforming growth factor
(TGF)-β signaling. MMPs are primarily responsible for the
structural degradation of extracellular matrices and sustained
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elevations lead to a breakdown of the structural proteins
that confer strength and resilience in skin. Furthermore, by
blocking the effects of TGF-β, there is a reduction of type
I procollagen gene expression [27]. These derangements in
the epidermis and dermis are hallmarks of photoaging and
clinically present as coarse wrinkles, solar lentigines, mottled hyperpigmentation, skin dullness, and telangiectasias
[32, 33]. Fisher et al. explored how skin pigment protects
against UV-induced responses that lead to collagen degradation [27]. In subjects with SPT I and II, exposure to 2 MED
of a UVB/UVA2 source resulted in substantial induction of
MMP-1 (collagenase) messenger RNA (mRNA) levels and
formation of thymine dimers. In contrast, twice the average exposure of this group produced only modest MMP-1
mRNA induction and DNA damage in subjects with SPT
V and VI.
Prominent features of photoaging vary depending on
skin type. Individuals with SPT I–III have reduced melanin content and small aggregates of melanosomes, making them more susceptible to UV damage and earlier signs
of photoaging. In this group, photoaging presents as lines
and wrinkles. Melanosomes in SOC are larger and contain
more melanin thus allowing less UV penetration, reducing
the impact of photoaging, and delaying the development of
wrinkles.
Other properties in the epidermal and dermal architecture
of SOC that contribute to differences in features of photoaging include a thicker and more compact dermis, increased
fibrillary collagen, and larger, more numerous, and multinucleated fibroblasts [34, 35]. In those with SOC, photoaging
is most associated with pigmentary changes, including uneven skin tone, post-inflammatory hyperpigmentation, and
melasma [5, 36]. To highlight the unique features of photoaging across skin types and ethnic groups, photonumeric
scales for evaluation of photodamage have been developed
for Caucasians [37, 38], Asians [39], and African Americans [40]. Photodamage accumulates in all skin types and all
individuals will at some point exhibit signs of photoaging.
Therefore, photoprotection is the most important method for
preventing photoaging.
2.3.3 Photocarcinogenesis
UVR is classified as a complete carcinogen as it has properties of both a tumor initiator and a tumor promoter [18].
Skin cancer is one of the most commonly occurring cancers in the world [41]. A combination of experimental and
epidemiological data suggests that the risk of skin cancer
is heavily influenced by cumulative UV exposure and skin
pigmentation. The incidence of melanoma and keratinocyte
carcinoma has been strongly correlated with history of sunburns and tanning bed use, SPT I–II with blonde or red hair,
and a personal or family history of skin cancer [42–45].
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The most important modifiable risk factor for skin cancer in non-Hispanic white populations is exposure to UV.
In contrast, in SOC, UV exposure is not believed to be as
important an etiologic factor in the pathogenesis of skin cancer. A systematic review assessing the association between
UV exposure and risk of melanoma development in SOC
found that in thirteen studies, 11 showed no association, 1
showed a small positive relationship in Black males, and 1
showed a weak association in Hispanic males [46]. Another
review evaluating the association between UV exposure and
development of keratinocyte carcinoma in SOC found that
the association may depend on the type of UV exposure. UV
exposure through phototherapy showed no association while
cumulative sun exposure demonstrated a positive association primarily in East Asian populations [47]. There were
no studies among Black individuals and only 1 study among
a Hispanic population. In both reviews, all the studies analyzed were rated as moderate to low quality (Oxford Centre
ratings 2b to 4) suggesting that further research is required
to fully elucidate this association with dark skin types.
The incidence rate of melanoma and keratinocyte carcinoma in different ethnic populations has been well reported
in several review articles [14, 48–51]. Non-Hispanic Whites
are reported to have 30 times higher incidence rates than
non-Hispanic Blacks or Asian/Pacific Islanders [52]. Incidence in individuals with SOC is about 5% in Hispanic, 4%
in Asian, and 2% in Black populations [14, 26]. A study by
Yamaguchi et al., assessed DNA damage in the epidermal
layers and subsequent apoptosis and phosphorylation of p53
at different time points following exposure to 1 MED of
UV (60% UVA and 40% UVB) [53]. This study classified
patients as fair or dark skin based on their race/ethnicity:
White subjects were grouped as “fair skin” and Black subjects as “dark skin”. They found that fair skin was less efficient at UV filtration, allowing for DNA damage in the lower
epidermis, including keratinocyte stem cells and melanocytes. Fair skin was also less efficient at removing UV-damaged cells with less than 1% of the damaged cells becoming
apoptotic. At the same UV dose, dark skin acquired less UVinduced DNA damage and had an increased rate of apoptotic
cell formation, greatly reducing the risk of carcinogenesis.
Although the incidence rate of skin cancer in SOC is
substantially lower than that of individuals who are not
SOC, when skin cancer does occur in SOC patients, they
face worse overall outcomes with increased morbidity and
mortality [14, 31, 54, 55]. It has been previously demonstrated that African Americans have a higher utilization of
Mohs Micrographic Surgery (MMS) compared to Caucasian
populations (44.2% vs 10.0%) [56] which would further suggest that skin cancers within this population may be more
aggressive at time of treatment than in white populations.
When skin cancer occurs in SOC, there is a greater propensity for inherently aggressive cancers with a higher risk

for tumor invasion and metastasis [50]. However, the poor
prognosis is likely multifactorial and due at least in part to
atypical clinical presentations resulting in delayed diagnosis
[57]. Structural inequalities in medicine and socioeconomic
factors, such as lack of access to health care (including dermatologic care), inadequate insurance coverage, and lack of
transportation, also contribute to the higher morbidity and
mortality seen in patients with SOC [58–60]. There is also
clinician bias and decreased index of suspicion among both
patients and providers due to lack of representation and data
in clinical research [61].

2.4 Effects of visible light
VL (400–700 nm) is a spectrum of electromagnetic radiation
to which the rods and cones of the human eye will respond.
Sunlight reaching the earth’s surface is composed approximately 50% VL; VL is also emitted by artificial sources
include light bulbs, computers, and cell phones, among others [62, 63].
Over the last several decades, studies in photodermatology focused mainly on the deleterious effects of UVR on
human skin. VL was regarded as having no photobiologic
effect; we only recently have begun to understand the cutaneous photobiologic effects of VL [62, 64, 65]. Most of the
currently available sunscreens only block wavelengths up to
380 nm and thus do not protect the skin from VL-induced
responses, highlighting the need for more effective photoprotection strategy [63].
2.4.1 Photoaging
Similar to UVR, VL may induce photoaging through alterations in extracellular matrix components. In a 2008 study,
skin samples of 16 human volunteers were taken 24 h postexposure to VL. Results showed significantly increased
MMP-1 and MMP-9 expression and decreased type I procollagen expression, comparable to the effects of UV irradiation
[66]. VL has also been shown to induce mitochondrial DNA
damage and free-radical production in epithelial cells [67].
An ex vivo study investigated ascorbate radical production
by solar-simulated light in human skin biopsies. Selective
filters were used to assess the relative contributions of UV
and visible wavelengths. Radical production by UV was
found to be about 67% while that of the visible component
accounted for about 33% [68].
Studies exploring skin response to isolated components
of solar light or a combination of these components suggest
that UV, visible, and infrared light have synergistic effects
[22]. Hudson et al. studied the effects of individual and interacting components of solar light on human donor primary
dermal fibroblasts and epidermal keratinocytes [69]. ROS
generation, mitochondrial DNA damage, and nuclear DNA
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damage were significantly increased in dermal fibroblasts
when exposed to complete solar-simulated radiation compared to each wavelength individually. Studies like this have
important implications as the interaction of the numerous
wavelengths is representative of the normal physiological
condition in sunlight.
2.4.2 Photocarcinogenesis
Although the role of UVR in photocarcinogenesis has been
well studied, there is paucity in the literature on the role of
and potential pathways for photocarcinogenesis induced by
VL. Published data suggest that the mechanism responsible for the genotoxic effects of VL differs from that in the
UV range. While direct damage through UV-induced dipyrimidine photoproducts is the major class of DNA lesion
involved in photocarcinogenesis, indirect damage through
the generation of ROS, especially in the presence of endogenous photosensitizers, is the most reported mechanism of
VL-induced DNA damage [70].
Kielbassa et al. analyzed DNA damage induced by UV
and VL by exposing mammalian cells to filtered monochrome or broad-band radiation. They found that while oxidative DNA damage formation was observed extending from
the UVA1 into VL range, beyond UVB (315 nm), the yield
of pyrimidine dimers per unit dose decreased exponentially.
DNA damage in the VL range was attributed to oxidative
damage induced by the excitation of endogenous photosensitizers [71]. On the other hand, Liebel et al. reported a lack
of thymine dimer formation in VL-irradiated tissues even
at concentrations sufficient to induce significant increases
in ROS [64].
2.4.3 Hyperpigmentation
Hyperpigmentation is a result of an increased amount of
melanin within the epidermis, the dermis, or both. Epidemiological studies show that hyperpigmentation is one of
the most common reasons why individuals with SOC visit
a dermatologist [72]. Post-inflammatory hyperpigmentation (PIH) is a common sequelae of inflammatory dermatoses that present with greater severity in SOC [73]. The
most common cause of hyperpigmentation is a result of a
post-inflammatory response to UV damage to skin [74].
Several studies have reported the impact of VL in inducing
immediate erythema in light and dark-skinned subjects, and
immediate pigment darkening, persistent pigment darkening and delayed tanning in dark-skinned subjects [75, 76].
These observations explain the prominent clinical manifestations of pigmentary changes seen in SOC, ranging from
post-inflammatory hyperpigmentation to melasma, which is
considered by some as part of the manifestation of photoaging process in SOC. This further highlights the importance
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of broad-spectrum photoprotection beyond UV wavelengths
in this population.
When compared to UVA, VL has been found to induce a
more prominent and long-lasting pigmentation in skin type
III and higher. Mahmoud et al. compared the effect of VLinduced and UVA-induced pigmentary change on immediate pigmentation and delayed tanning [77]. Volunteers were
irradiated and cutaneous pigmentary changes, erythema, and
edema were assessed by visual examination, digital photography, and spectroscopy over a 2-week period. Results were
dose-dependent with higher irradiation doses resulting in
darker pigmentation responses in subjects with skin types
IV–VI. However, no pigmentation was induced in SPT II.
Notably, VL-induced pigmentation was more intense and
persistent, lasting for the 2-week study period compared to
UV-induced pigmentary change, which quickly faded during
the study period. Additionally, erythema was noted immediately after VL irradiation, whereas UVA1 (340–400 nm)
caused no erythema at any time point after irradiation.
Specific wavelengths within the VL spectrum have been
found to induce different skin responses. Dutiel et al. examined the photobiological effects of wavelengths located at
both extremities of the VL spectrum on pigmentation in skin
types III and IV [78]. Monochromatic radiation with blue/
violet light (λ = 415 nm) and red light (λ = 630 nm) were
compared to non-exposed and UVB-exposed skin. Blue/
violet light induced a dose-dependent hyperpigmentation
response whereas red light induced no hyperpigmentation.
Furthermore, blue/violet light-induced hyperpigmentation
was more pronounced and long-lasting than UVB-induced
pigment change.
The mechanism of VL-induced pigmentation has been
shown by Regazzetti et al. to be through activation of the
Opsin-3 (OPN3), a key sensor for visible light pigmentation
in melanocytes [79]. Stimulation of OPN3 by blue light leads
to the phosphorylation of microphthalmia-associated transcription factor (MITF) and ultimately increased melanogenesis enzymes: tyrosinase and dopachrome tautomerase.

2.5 Photoprotection in SOC
2.5.1 Photoprotective practices in SOC
Photoprotective measures can mitigate and prevent the damaging effects of UV and VL radiation highlighted above.
As outlined in Table 2, such measures can include avoiding
sunlight during peak hours from 10 a.m. to 2 p.m., staying
in the shade while outdoors, wearing sun-protective clothing, wide-brimmed hat, sunglasses, and applying sunscreen
(SPF ≥ 30, broad spectrum, and especially for dark-skinned
individuals, tinted) [80]. Photoprotective practices differ
widely among SPT I–VI populations. A study found that in
a large group of individuals participating in a skin cancer
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Table 2  Options for photoprotection in individuals with SOC

screening program, White and Hispanic individuals were
more likely to report having used sunscreens in the previous
year compared with Black individuals [81]. SOC populations have historically not been counseled to photoprotect to
the same degree as light skinned populations [4]. Although
the benefits of sun protection in defending against sunburns,
photoaging, and skin cancer are well studied in SPTs I–III,
the same is not true in SPTs IV–VI.
The underlying reasons for differences between photoprotection among patients with SPT I–III versus those with SPT
IV–VI have been studied mostly in the US. There is a lack
of representation of SPTs greater than III in medical student
resources [82] and dermatology textbook photos [83]. One
survey of dermatology trainees and board-certified dermatologists found that 42.9% of respondents reported that they
“never, rarely, or only sometimes” based sunscreen recommendations on their patients’ skin type [84]. In a National
Ambulatory Medical Care Survey, dermatologists recorded
mentioning sunscreen in only 1.6% of all dermatology visits,
and most commonly mentioned sunscreen to white patients
[85]. Recently, researchers have taken efforts to dispel the
many misconceptions that exist with regards to photoprotection for SOC to bridge the photoprotection gap SOC populations face [5]. Furthermore, expert guidelines on phototherapy for SOC have been published to aid clinicians in
providing high-quality, evidence-based recommendations for
their SOC patients [86].
2.5.2 Role of sunscreen
a. Protection against UVB, UVA and VL
	  Sunscreens are made from active ingredients called
filters and are labeled based on their sun protection factor (SPF) and UVA protection factor (UVA-PF). SPF is
determined by calculating the ratio of minimum erythematous dose (MED), i.e., the minimum dose of UV radi-

ation that elicits erythema, on sunscreen-protected vs
not sunscreen-protected skin. It is therefore a reflection
of primarily the effect of UVB, and to a lesser extent,
UVA2 (320–340 nm) [87]. Though there are different
methods to calculate UVA-PF, one common technique
involves determining the level of UVA exposure leading
to persistent pigment darkening (PPD) [88]. UVA-PF
is then a ratio of PPD on sunscreen-protect skin vs not
sunscreen-protected skin. Regulatory agency in Japan
introduced categorization of PPD measurements into a
range from PA+ (some protection) to PA++++ (excellent protection) [89]. European guidelines dictate a
minimum UVA-PF/SPF ratio of 1:3 for sunscreens and
a critical wavelength of ≥ 370 nm [90, 91]. In the United
States, the Food and Drug Administration (FDA) utilizes a critical wavelength determination and classifies
sunscreens as “broad spectrum” should their 90% UV
absorbance occur at ≥ 370 nm [92]. Currently published
VL protection assessment methods have been reviewed,
and a VL protection method has been proposed [93].
However, there is no standardized test for VL protection
in sunscreen.
	  The biological differences in skin of color response
to UVA, UVB, and VL highlighted earlier in this
review allows for tailoring sunscreen recommendations
for SOC. There is a stronger need among SOC to protect against UVA and VL due to greater propensity for
hyperpigmentary disorders. Thus, sunscreens worn by
SOC populations should be chosen not only for the protection against UVB and UVA2 (320–340 nm) to prevent erythema, but also against UVA1 and VL to prevent
hyperpigmentation. Skin phototype can be used to guide
selection of sunscreen with different spectral absorption profiles and protection factors (PF) (Fig. 2) [94].
For SPT IV-VI, sunscreen with SPF30+ and an UVAPF/SPF ratio ≥ 2/3 addresses the unique photoprotective needs of SOC [94]. In contrast, SPT I–III requires
SPF-50+ (given the relatively greater protection against
UVB) and an UVA-PF/SPF ratio ≥ 1/3 [94]. While such
“broad spectrum” sunscreens by definition protect
against UVA and UVB, they do not protect against VL.
Tinted sunscreens offer the VL protection lacking in
broad-spectrum sunscreens by leveraging iron oxides
and pigmentary titanium dioxides in their formulations
[95]. Of note, titanium dioxides must be pigmentary and
not micronized to offer VL protection [96].
	  Recently, three new filters have been developed that
extend coverage to the longwave UVA and VL spectra. An in vitro study evaluated the addition of methoxypropylamino cyclohexenylidene (MCE), a UVA1
filter which absorbs UV rays at a peak wavelength
of 385 nm [97]. Addition of 0.7% MCE resulted in
UVA1 absorption up to 385 nm and addition of 1.5%
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Fig. 2  SPF/UPF for different skin phototypes. Sunscreen should be
chosen based on the SPT; for example, individuals with SPT IV–VI
should opt for a sunscreen with a UVA-PF/SPF ratio of > 2/3 and with
an SPF minimum of 30 or higher. Individuals with SPT I–II should

choose a sunscreen with SPF-50+ but a UVA-PF-SPF ratio of > 1/3 is
typically sufficient. Individuals with SPT III may opt for more intermediary SPF such as 40+. Adapted from Passeron et al. [94]

MCE resulted in absorption up to 400 nm in a threedimensional human skin model, while also decreasing
UVA1-induced hyperpigmentation compared to the
control sunscreen. Another filter, TriAsorB, from the
1,2,4-triazine family of compounds, was found to provide coverage up to the blue light wavelength in the visible light spectrum and protected skin from VL-induced
oxidative skin damage [98]. A third organic filter, bis(diethylaminohydroxybenzoyl benzoyl) piperazine
(BDBP), absorbs between 350 and 425 nm; it has been
shown to protect against pigmentation induced by 385–
405 nm radiation [99]. All of these filters have now been
approved by EU regulatory agency and incorporated in
commercial sunscreens available in EU.
	  A common concern with daily sunscreen use is the
potential for compromised vitamin D synthesis; however, there has been no definitive evidence that regular
sunscreen use decreases vitamin D synthesis, even when
sunscreen is applied under optimal conditions [100,
101]. Based on a study of over 3400 individuals in the
US, routine practice of photoprotection (shade, clothing,
sunscreen) was not associated with decreased bone mineral density or increased in osteoporotic fracture [102].
b. Treatment and prevention of pigmentary disorders
	  The use of sunscreen has been shown to help reduce
and prevent pigmentary disorders including PIH and
melasma [103]. Patients undergoing laser therapies are
often advised to avoid sun exposure and to apply sunscreen regularly for several weeks following treatment
to prevent new hyperpigmentation [103, 104]. A study
showed that daily sunscreen use can prevent development of PIH post-procedurally [105]; and another study
demonstrated that it can also lighten existing hyperpigmentation, with greater improvement seen with application of SPF 60 compared to SPF30 sunscreens [106].

	  While the pathogenesis of melasma is multifactorial, an important cause is sun exposure. In a study
of 185 Moroccan women using SPF-50 UVA-PF 28
sunscreen every two hours, assessments were made
based on patient self-reported pigmentation outcomes
and colorimetry measurements at 3-, 6-, and 12-month
intervals. With consistent sunscreen use, only 5 new
cases of melasma (2.7%) occurred, as compared to an
incidence of 53% in a study by the same investigators
with a similar population, geographic region, and time
frame. Additionally, 8 of 12 patients (67%) with preexisting melasma noted improvement in their disease.
This study demonstrated that regular sunscreen use was
effective at reducing incidence of melasma, though the
validity of the study is limited by lack of control group
[107]. Regular sunscreen use has also been shown to
improve preexisting melasma. A study of 100 patients
(80 women, 20 men) with SPT III-IV and melasma primarily of the cheeks and nose were instructed to apply
SPF 19 PA+++ sunscreen three times daily. Melasma
area severity index (MASI) scores were assessed at
baseline and at 12 weeks after daily sunscreen use.
MASI scores decreased from 12.38 to 9.15, a statistically significant change, with concurrent improvement
in Melasma Quality of Life (MELASQOL) scores [108].
The researchers concluded that regular sunscreen use is
effective at improving existing melasma and improving
melasma-related quality of life [108]. Very few studies have been done on the efficacy of tinted sunscreen
in melasma. This represents an area in need of further
research. One open-label single-site study of 10 female
subjects found that use of a 30% tetrahexyldecyl (THD)
ascorbate serum plus a mineral-based tinted SPF 45 sunscreen resulted in improvement in skin tone evenness
and erythema in 7 out of 10 (70%) subjects [109].
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c. Sunscreen with depigmenting agents
	  Sunscreens that contain depigmenting agents can be
particularly helpful for patients with pigmentary disorders. Commonly used depigmenting agents in the treatment of melasma include hydroquinone, niacinamide,
vitamin E, and thiamidol. A randomized controlled trial
of 35 Hispanic FST III–V women undergoing twice
daily application of a sunscreen (SPF was not stated)
containing 4% hydroquinone plus 10% glycolic acid,
vitamin C and vitamin E versus sunscreen-only control
for 12 weeks found significantly improved pigmentation
in the hydroquinone containing sunscreen group [110].
A randomized controlled trial of 27 SPT IV–V women
treated with 4% hydroquinone versus 4% niacinamide
did not find significant differences in clinical outcomes
between the two treatments, as assessed by MASI, Physicians Global Assessment and colorimetric assessment
[111]. A randomized controlled trial evaluating 4%
hydroquinone versus 0.2% thiamidol (a tyrosine kinase
inhibitor) in the treatment of melasma amongst a group
of SPT IV–V found no statistically significant difference in MASI, MELASQOL, colourimetric contrast, or
Global esthetic Improvement Scale scores. Both groups
saw statistically significant reductions in all outcomes
with use of the depigmenting agents [112].
d. Sunscreen with antioxidants
	  Sunscreens may also contain other additives such as
antioxidants to combat the free radicals that occur from
exposure to UVR and VL. Free radicals on the skin are
known to cause DNA damage, hyperpigmentation, and
melanogenesis [113]. Exogenous antioxidants thus play
a role in supporting the skin’s own endogenous antioxidants that minimize the damaging effects of free radicals
and reactive oxygen species [113]. Such antioxidants can
include ascorbate (vitamin C), tocopherols, carotenoids,
polyphenols, and flavenoids [114].
	  Vitamin C is normally found in large, plentiful levels
in the skin, aiding the skin’s natural defenses against
UV-induced photodamage and stimulating collagen
synthesis to improve the elasticity of skin [115]; however, older or photodamaged skin has been found to have
depleted levels of vitamin C [116]. Numerous studies
have evaluated the use of topical vitamin C in protecting against erythema and sunburn [117–119], as well
as improving existing photodamage [120]. Vitamin E
also protects keratinocytes from UVA1-induced pyridine
dimer and oxidatively- generated DNA damage [121].
The combination of topical vitamin C and vitamin E
provides superior protection, especially when used daily,
as compared to the use of vitamin C or vitamin E alone
[118].
	  Antioxidants, and sunscreen containing antioxidants,
have been shown to decrease VL and UVA1-induced

pigmentation in dark-skinned subjects [122, 123]. In an
open-label, single-center, 12-week study, sunscreen containing photolyase and antioxidants have been shown to
improve photoaging changes [124]. It should be noted
that while antioxidants are beneficial as adjuvants, they
should not replace the sunscreen and other photoprotective measures as sole agents.
e. Tinted sunscreen & cosmetic elegance
	  Improving cosmetic appearance of sunscreen can
help improve compliance of regular sunscreen use. The
transparency of the sunscreen application and reduction
of white residue is important especially given the potential contrast on dark skin [95]. To reduce the whiteness
and chalkiness of sunscreens, formulations often utilize
mineral (inorganic) filters composed of nanoparticles
of zinc oxide or titanium dioxide; however, in order
for sunscreens to provide VL protection, they must be
visible on the skin, i.e., tinted [95]. Tinted sunscreens,
containing iron oxides and/or pigmentary titanium
dioxide, can also be leveraged to improve adherence by
color-matching to dark skin while also evening out the
appearance of hyperpigmented areas. A 2020 survey of
dermatology trainees and board-certified dermatologists
found that respondents regarded the cosmetic elegance
of a sunscreen the least important factor when forming
recommendations for their patients [84]. This, in combination with the finding that dermatologists counseled
their SOC patients less on sunscreen use compared to
other patients, highlights the need for more culturally
competent training and care by dermatologists [73].
Having a familiarity with the breadth of sunscreen formulations and which are more suited to SOC—not only
in regards to UV and VL protection but also considering the cosmetic elegance–will hopefully boost patient
adherence to sunscreen application. A practical guide to
tinted sunscreens has been recently published [125].

2.6 Role of sun‑protective clothing
Aside from sunscreens, other photoprotective measures
include sunglasses, wide-brimmed hats, and articles of
clothing such as long-sleeved shirts and pants. Although
sun-protective clothing has been found to block UVR better
than sunscreen, use of sun-protective clothing lags behind
other photoprotection measures [126]. A cross-sectional
analysis of the National Health and Nutrition Examination
survey of respondents aged 20–60 from 2003 to 2006 found
that sunscreen was the most common sun-protective measure
Americans utilized (30% of respondents), while even less
sought shade frequently (24%), wore a hat (16%), or wore
long sleeves (4%).
Interestingly, they found that the odds of sunburn was
decreased in individuals seeking shade or frequently wearing
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long sleeves, and higher in those frequently wearing sunscreen [127]. This is likely related to the fact that consumers
rarely apply sunscreen as appropriately or frequently as recommended (2 mg/cm2 and reapplied every two hours when
outdoors) whereas wearing photoprotective clothing is less
likely to be subject to user error [128]. Additionally, the use
of sunscreen has been associated with longer intentional sun
exposure leading to sunburn [129]. A major limitation of this
study is that it was limited to non-Hispanic White respondents. Other articles have demonstrated that non-Hispanic
Black Americans are more likely to practice sun avoidance
and wear sun-protective clothing as opposed to sunscreen
[130]. Hispanics have demonstrated decreased likelihood
of seeking shade and wearing sun-protective clothing with
acculturation to US norms [131]. An important benefit of
sun avoidance and sun-protective clothing is a decreased
odds of sunburn [132], and the resultant photoaging and
hyperpigmentation in SOC.
Clothing provides protection from the sun by scattering
or absorbing UVR. Commercially available clothing does
not necessarily protect well against UVA and UVB, with
data suggesting that one-third of summer clothing articles
have an Ultraviolet Protective Factor (UPF) of less than 15
[133]. Patients should seek UPF labeled clothing, which is
manufactured with tightly woven fibers and tested to determine the UPF values [133]. Various factors affect the degree
of UPF protection, including the color, material, and fiber
quality used [134, 135]. Other factors that affect the performance of UPF clothing include stretching, shrinking, wetting, washing, or laundering; because of this, the minimum
UPF level recommended is 40 to 50, or higher [136].
Limitations to sun-protective clothing include undesirability of being fully clothed in hot or humid environments,
inability to cover all exposed skin surfaces with clothing at
all times, and finding UPF clothing that is lightweight and
moisture-wicking [126]. Cost could be a barrier to accessing
high-quality, effective UPF clothing, although this does not
appear to have been examined yet in the literature.

2.7 Role of oral agents
a. Vitamins
	  Oral photoprotective agents include antioxidants, antiinflammatories, and immunomodulators [137]. One of
the better studied classes of oral photoprotective agents
is vitamins. Carotenoids-pigments that occur naturally
in fruits and vegetables-work by decreasing ROS [138].
Vitamin E (α-tocopherol) prevents production of ROS
during lipoxidation and during the free-radical reaction,
mitigating UVA1-induced keratinocyte damage [121].
Vitamin E, when taken together with vitamin C [139]
or carotenoids [140], has synergistic protection against
UV-mediated skin damage. Oral vitamin C supplemen-

13

tation alone, however, has not been shown to reduce UVmediated erythema [141].
b. Polypodium leucotomos
	 
Polypodium leucotomos is a fern found in Central and
South America that is harvested for Polypodium leucotomos extract (PLE), an over-the-counter UV protectant [142]. Among oral photoprotective agents, PLE has
been most well studied. A review on the effect of PLE
highlighted that PLE exerts photoprotective properties
by preventing UV and VL-induced extracellular matrix
degradation, while it wields antiinflammatory properties by inhibiting UV- induced immunosuppression
[142]. Studies on PLE photoprotection have been done
in vitro, in animal models and in human subjects [142].
The human studies have small sample sizes; Mohammad et al. conducted a prospective clinical trial of 22
volunteers with FST IV-VI who were treated with PLE
then irradiated with VL (up to 480 J/cm2). They found
a decrease in VL- induced pigmentation, and a statistically significant decrease in inflammatory marker
COX-2 and MART-2 (melanocytic marker of pigmentation) in the PLE treated skin [143]. Truchuelo et al.
report a study of 7 volunteers whose gluteal skin was
irradiated with a single dose of VL (200 J/cm2) and IR
(600 J/cm2) and who took oral PLE supplementation for
21 days. They found a statistically significant decrease
of 52% in MMP-1 expression in participant’s skin, demonstrating PLE’s ability to reduce extracellular matrix
degradation [144]. Goh et al. conducted a double-blind,
placebo-controlled trial of 40 patients with melasma and
receiving treatment with topical 4% hydroquinone cream
and sunscreen with a SPF of 50+. The subjects were
randomized to receive either oral PLE supplementation
or placebo for 12 weeks. The modified Melasma Area
and Severity Index (mMASI) scores of the PLE group
at 12 weeks were significantly lower than those of the
placebo group [145].
	  In contrast, Ahmed et al.’s study evaluating the effectiveness of PLE UVR amongst a group of Hispanic
women showed no statistically significant benefit to PLE
supplementation. Thirty-three patients were randomized
to oral PLE or placebo three times daily for 12 weeks;
all subjects were instructed to apply broad-spectrum
SPF 55 sunscreen every morning. Researchers assessed
the change in melanin index from baseline at 6 and
12 weeks. They found statistically significant improvements in melanin index scores between weeks 0 and
12 for both groups (28.8% improvement in PLE group;
13.8% improvement in placebo group), with no statistically significant difference in melanin index between
groups [146]. Though the results did not support the
hypothesis that PLE would result in significant improvement in melanin index, the sample size was small and
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limited the power to detect a significant difference. The
study also reinforces the effectiveness of sunscreen in
improving existing melasma, as discussed earlier in this
review paper.
c. Pinus pinaster
	 
Pinus pinaster is an extract from the French maritime pine bark containing proanthocyanidins and other
antioxidants which has been formulated into a standardized extract called Pycnogenol. A prospective study
of 30 women who took Pycnogenol 25 mg three times
daily with meals for 30 days assessed melasma area
indices and pigment intensity indices after treatment.
Upon completion of the study, participants had an average melasma area index decrease of 25.86 mm2 [147].
Another study by Aladrén et al. of 30 women with FST
I–V and melasma investigated the use of Pinus pinaster
and grapeseed oil containing supplements. Participants
took two supplement capsules every morning and wore
SPF-50 sunscreen daily. Investigators measured MASI
scores, Physician Global Assessment, Patient Global
Assessment, and Melasma Assessment by VISIA Complexion Analysis Images at Days 28, 56, and 84. Participants had a statistically significant decrease in MASI
scores at all three follow-up intervals (− 28% at Day 28,
− 33.7% at Day 56, − 41.1% at Day 84). VISIA Complexion analyses found a statistically significant reduction in melasma spots of 15.3% at Day 28, 28.6% at
Day 56, and 46.2% at Day 84. Remarkably, 96.7% of
participants reported self-improvement and 93.3% of
physicians noted improvement of their hyperpigmentation [148]. This study is limited by lack of control group,
with unknown contribution of the Pinus pinaster versus
sunscreen in reduction of the hyperpigmentation.
	  Numerous other oral photoprotective botanicals exist,
including green tea, pomegranate, reservatrol, turmeric,
and silmarin [149]. In summary, data is emerging that
oral photoprotective agents are potentially useful adjuvant in comprehensive photoprotection strategy.

3 Conclusion
Though dark skin individuals are less afflicted by UV-erythema, photoaging and photocarcinogenesis given natural
protection from melanin in the skin, they are disproportionately affected by hyperpigmentary disorders. Understanding
the unique considerations of SOC reaction to sun exposure
helps clinicians tailor photoprotective recommendations
for their patients. Healthcare providers should have a good
basic understanding of the effects of UVA, UVB and VL on
the skin, so that they would be comfortable in counseling
SOC patients on sun exposure, risks for photodamage and
pigmentary disorders, and methods for photoprotection.

The general public should be encouraged to utilize multiple methods of photoprotection, ranging from avoidance of
sunlight during peak intensity hours, seeking shade, wearing sun-protective clothing and wide-brimmed hat, and
applying sunscreen. Sunscreens that are most appropriate
for SOC populations are those with SPF30+, UVA-PF/SPF
ratios ≥ 2/3 and tinted. Emerging data shows that topical
antioxidants and oral photoprotective agents might be useful adjuvants in photoprotection. Although there have been
increased efforts recently, more research into photoprotection for SOC and targeted public education is required to disseminate photoprotection resources that are patient-centered
and evidence-based.
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